Henry Schein, Inc. (HSIC) Receives $84.23 Average PT from Brokerages
Henry Schein, Inc. (NASDAQ:HSIC) has received a consensus rating of “Hold” from the nineteen ratings firms that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating on the company. The average 12-month target price among analysts that have covered the stock in the last year is $84.23.
A number of research analysts have weighed in on HSIC shares. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, November 13th. Stifel Nicolaus decreased their target price on Henry Schein from $89.00 to $77.00 and set a “hold” rating for the company in a research note on Tuesday, November 7th. Craig Hallum upgraded Henry Schein from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. Evercore ISI began coverage on Henry Schein in a research note on Thursday, January 4th. They issued an “outperform” rating and a $81.00 target price for the company. Finally, Leerink Swann restated a “hold” rating on shares of Henry Schein in a research note on Tuesday, February 13th.
In other news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the sale, the director now owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 1.19% of the company’s stock.
Shares of Henry Schein (NASDAQ HSIC) traded up $1.14 during trading on Tuesday, hitting $69.52. The company’s stock had a trading volume of 2,870,000 shares, compared to its average volume of 2,265,329. Henry Schein has a one year low of $63.01 and a one year high of $93.50. The stock has a market cap of $10,911.44, a price-to-earnings ratio of 20.03, a PEG ratio of 1.79 and a beta of 1.00. The company has a current ratio of 1.55, a quick ratio of 0.86 and a debt-to-equity ratio of 0.30.
TRADEMARK VIOLATION NOTICE: “Henry Schein, Inc. (HSIC) Receives $84.23 Average PT from Brokerages” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2018/02/18/henry-schein-inc-hsic-receives-84-23-average-pt-from-brokerages.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.